main content start
Ozempic (semaglutide) injection is a once-weekly medication in the GLP-1 receptor agonist class of drugs. It is used in adults with type 2 diabetes, along with diet and exercise, to improve glucose. It is also used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease. It helps to release insulin and lowers the amount of glucose produced by the liver when glucose rises at mealtime. It also slows the absorption of mealtime glucose. Ozempic has been approved at a 2 mg dose if additional blood glucose management is needed.
- Helps manage blood glucose in adults with type 2 diabetes, not suitable for people with type 1 diabetes.
- Use can result in weight loss. Semaglutide is separately approved under the brand name Wegovy to treat obesity.
- Promotes weight loss by slowing gastric emptying and increasing satiety, though not FDA-approved solely for weight management
- Reduces cardiovascular and kidney risk in people with heart and kidney disease.
- Reduces cardiovascular and kidney risk in people with heart and kidney disease.
Ozempic Specs
Key specification
Generic Name
Semaglutide
Drug Class
GLP-1 receptor agonists
Type
Injected
General Information
Product Name
Ozempic
Product Type
Injectable Medications
Brand
Novo Nordisk
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
